Resumen

BANUELOS-HERNANDEZ, Bernardo et al. Using the TiLV virus genome sequence to develop a recombinant oral vaccine in microalgae. Comment to the article "Complete Genome Sequence of a Tilapia Lake Virus Isolate Obtained from Nile Tilapia (Oreochromis niloticus)". Nova scientia [online]. 2020, vol.12, n.24.  Epub 02-Jul-2020. ISSN 2007-0705.  https://doi.org/10.21640/ns.v12i24.2073.

High mortality and dissemination rates of the emerging virus TiLV (Tilapia lake Virus) leads the researcher to develop a novel strategies to prevent these kind of infections in the fish. In viral diseases, vaccination is the most recommended method for prevention. In this context and considering the genome sequences of TiLV virus published in the article “Complete Genome Sequence of a Tilapia Lake Virus Isolate Obtained from Nile Tilapia (Oreochromis niloticus)”, we propose to produce a recombinant oral vaccine through microalgae biotechnology using viral vectors.

Palabras llave : microalgae; TiLV; vaccine; viral vector.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )